Variant: rs80359636 

    present in Gene: BRCA2
    present in Chromosome: 13
    Position on Chromosome: 32354921
    Alleles of this Variant: CT/-

rs80359636 in BRCA2 gene and Abnormal behavior PMID 23628597 2013 Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

PMID 19188187 2009 Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.

PMID 18855126 2009 Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

PMID 20587410 2010 Risk of breast cancer in male BRCA2 carriers.

PMID 16141007 2005 Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

PMID 18042939 2007 Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

rs80359636 in BRCA2 gene and Attention deficit hyperactivity disorder PMID 19188187 2009 Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.

PMID 18042939 2007 Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

PMID 20587410 2010 Risk of breast cancer in male BRCA2 carriers.

PMID 23628597 2013 Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

PMID 18855126 2009 Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

PMID 16141007 2005 Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

rs80359636 in BRCA2 gene and BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2 PMID 20587410 2010 Risk of breast cancer in male BRCA2 carriers.

PMID 23628597 2013 Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

PMID 20104584 2010 Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.

PMID 18855126 2009 Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

PMID 19188187 2009 Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.

PMID 16141007 2005 Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

PMID 21324516 2011 Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

PMID 22762150 2012 Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

PMID 18042939 2007 Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

rs80359636 in BRCA2 gene and Global developmental delay PMID 16141007 2005 Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

PMID 18855126 2009 Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

PMID 20587410 2010 Risk of breast cancer in male BRCA2 carriers.

PMID 18042939 2007 Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

PMID 23628597 2013 Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

PMID 19188187 2009 Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.

rs80359636 in BRCA2 gene and Hereditary Breast and Ovarian Cancer Syndrome PMID 24549055 2014 Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.

PMID 9429140 1997 BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.

PMID 21120943 2011 EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients.

PMID 24728189 2014 The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.

PMID 20104584 2010 Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.

PMID 18824701 2008 Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.

PMID 16234499 2005 Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

PMID 18465347 2008 BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

PMID 21324516 2011 Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

PMID 24504028 2014 Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status.

PMID 9667259 1998 Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

rs80359636 in BRCA2 gene and Neoplastic Syndromes, Hereditary PMID 9429140 1997 BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.

PMID 21913181 2012 Earlier age of onset of BRCA mutation-related cancers in subsequent generations.

PMID 24504028 2014 Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status.

PMID 21324516 2011 Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

PMID 23725378 2014 Linking distant relatives with BRCA gene mutations: potential for cost savings.

PMID 24830819 2014 The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay.

PMID 24728189 2014 The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.

PMID 27978560 2017 Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

PMID 18465347 2008 BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

PMID 20104584 2010 Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.

PMID 11836363 2002 Unique de novo mutation of BRCA2 in a woman with early onset breast cancer.

rs80359636 in BRCA2 gene and Overgrowth PMID 16141007 2005 Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

PMID 18042939 2007 Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

PMID 23628597 2013 Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

PMID 18855126 2009 Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

PMID 20587410 2010 Risk of breast cancer in male BRCA2 carriers.

PMID 19188187 2009 Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.